FDA lists 20 drugs under review for safety risks

09/7/2008 | Wall Street Journal, The

The FDA released a list of 20 medicines being investigated for potential adverse effects to provide early warnings to consumers and health care professionals. The list includes Eli Lilly and Co.'s Cymbalta, an antidepressant, and Purdue Pharma's OxyContin, a pain medication. Companies expressed support for the agency's drug-safety efforts, but some are concerned that data presented to patients lack context and may affect the course of their treatment.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA